We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.
The MHRA’s Criminal Enforcement Unit works to identify and prevent the illegal sale of weight-loss medicines online.
This article presents findings from a systematic review and meta-analysis
Practical advice and tools to support health and care professionals make brief interventions in weight management for adults.
Find a BFPO number, send mail to and from British forces personnel and their families
How to use a before-and-after study to evaluate your digital health product.
Outlining the shared commitment of professional organisations working together to support the public health workforce to have healthier weight conversations.
GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro and Wegovy
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).